首页 | 本学科首页   官方微博 | 高级检索  
     

脑脊液MyD88L265P基因突变对原发性中枢神经系统淋巴瘤预后的影响
引用本文:陈锟,马晶晶,王迪,李向宇,秦欢欢,林之光,马燕,陈波斌,关明. 脑脊液MyD88L265P基因突变对原发性中枢神经系统淋巴瘤预后的影响[J]. 中华检验医学杂志, 2022, 0(1): 51-57
作者姓名:陈锟  马晶晶  王迪  李向宇  秦欢欢  林之光  马燕  陈波斌  关明
作者单位:复旦大学附属华山医院北院检验科;复旦大学附属华山医院北院血液科
摘    要:目的:分析比较脑脊液髓样分化因子88L265P(MyD88L265P)突变和白细胞介素10(IL-10)与原发性中枢神经系统淋巴瘤(PCNSL)预后的关系。方法:收集2013年8月至2016年12月间复旦大学附属华山医院北院经手术或定位穿刺病理确诊的39例初发PCNSL患者(男18例,女21例,年龄40~73岁)的病例...

关 键 词:原发中枢神经系统淋巴瘤  脑脊液  白细胞介素10  预后  实验室技术和方法

Prognostic effect of MyD88L265P gene mutation in cerebrospinal fluid in primary central nervous system lymphoma
Chen Kun,Ma Jingjing,Wang Di,Li Xiangyu,Qin Huanhuan,Lin Zhiguang,Ma Yan,Chen Bobin,Guan Ming. Prognostic effect of MyD88L265P gene mutation in cerebrospinal fluid in primary central nervous system lymphoma[J]. Chinese Journal of Laboratory Medicine, 2022, 0(1): 51-57
Authors:Chen Kun  Ma Jingjing  Wang Di  Li Xiangyu  Qin Huanhuan  Lin Zhiguang  Ma Yan  Chen Bobin  Guan Ming
Affiliation:(Department of Laboratory Medicine,Hua Shan Hospital North,Fudan University,Shanghai 200040,China;Department of Hematology,Hua Shan Hospital North,Fudan University,Shanghai 200040,China)
Abstract:Objective This study has investigated the value of detecting cerebrospinal fluid(CSF)MyD88L265P mutation and interleukin-10(IL-10)levels in the prognosis of PCNSL.Methods We retrospectively analyzed the clinical data,CSF characteristics(including cytology,cell counting,total protein,and the level of cytokine IL-10)and treatment process of 39 PCNSL patients newly diagnosed by surgery and pathology(18 males and 21 females,aged 40-73 years)from August 2013 to December 2016 in Hua Shan Hospital North.MyD88L265P mutation was detected by digital PCR in 39 paraffin-embedded tissues and 35 cerebrospinal fluid samples.Log-rank test was used for univariate analysis and Cox regression for multivariate analysis to establish the prognosis model of PCNSL which might be related to PCNSL first progress-free survival(PFS)and overall survival(OS).Results The median age of the 39 PCNSL patients was 59 years old,with 30.8%(12/39)intraocular involvement.The mutation rate of MyD88L265P in tissues and cerebrospinal fluid was 74.4%(29/39)and 40.0%(14/35),respectively.51.9%(14/27)patients were observed with MyD88L265P mutation in both tissues and CFS.Univariate analysis showed that intraocular involvement,high level of IL-10 in CFS(≥45 pg/ml),and MyD88L265P mutation in CFS are factors significantly influencing median progression-free survival(mPFS)of patients(P<0.05).Patients with intraocular involvement had shorter OS than those without involvement which was statistically significant(HR=6.5,95%CI 1.7-47.3,P<0.05).And multivariate analysis showed that intraocular involvement(HR=2.4,95%CI 1.3-7.8,P<0.05)and CFS MyD88L265P mutation(HR=2.1,95%CI 1.1-5.7,P<0.05)were independent prognostic factors for PFS.Conclusion The presence of intraocular involvement and MyD88L265P mutation in CFS indicated poor prognosis of PCNSL patients.High CSF IL-10 level was not an independent factor affecting prognosis.
Keywords:Primary central nervous system lymphoma  Cerebrospinal fluid  Interleukin-10  Prognosis  Laboratory techniques and procedures
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号